Beta Bionics, Inc. (BBNX) Equity Average (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Equity Average data on file, last reported at $279.4 million in Q1 2026.

• Quarterly Equity Average rose 717.14% year-over-year to $279.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $279.4 million (up 717.14% YoY) and the FY2025 annual result came in at $21.1 million, up 109.42% from the prior year.
• Equity Average slipped to $279.4 million in Q1 2026 per BBNX's latest filing, from $291.2 million in the prior quarter.
• The five-year high for Equity Average was $307.7 million in Q2 2025, with the low at -$237.1 million in Q4 2024.
• Average Equity Average over 3 years is $35.8 million, with a median of $34.2 million recorded in 2025.
• Year-over-year, Equity Average surged 116.38% in 2025 and jumped 717.14% in 2026.
• Beta Bionics' Equity Average stood at -$237.1 million in 2024, then soared by 222.81% to $291.2 million in 2025, then declined by 4.04% to $279.4 million in 2026.
• Business Quant data shows BBNX's Equity Average at $279.4 million in Q1 2026, $291.2 million in Q4 2025, and $298.2 million in Q3 2025.